Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)
In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...
pharmaphorum22h
Determining the right royalty rate: key to pharmaceutical and biotechnology success
That is attractive as a simple option, but it also ignores the investments and risks you take bringing the product to market, and it doesn’t consider your profitability as a measure of success.
pharmaphorum22h
The B2C prescription: Marketing lessons for B2B pharma companies
Some pharmaceutical brands are even experimenting with influencers, including a recent campaign from Gilead Science. Meanwhile, Kantar recorded a 208% jump in spending on podcast pharma ads in ...